Herbal-moxa plaster for diarrhea type irritable bowel syndrome of spleen and kidney yang deficiency: a randomized controlled trial.
10.13703/j.0255-2930.20220804-k0001
- Author:
Zheng-Rong ZHAO
1
;
Ya-Xuan WANG
1
;
Fang-Yuan XU
1
;
Wen-Chao ZHANG
1
;
Qiao-Yun WANG
1
;
Wei HUANG
2
,
3
,
4
Author Information
1. College of Acupuncture-Moxibustion and Orthopedics-Traumatology, Hubei University of CM, Wuhan 430061, China.
2. College of Acupuncture-Moxibustion and Orthopedics-Traumatology, Hubei University of CM, Wuhan 430061, China
3. Hubei Provincial Collaborative Innovation Center for Preventive Treatment of Disease by Acupuncture and Moxibustion, Wuhan 430061
4. Department of Acupuncture and Moxibustion, Hubei Hospital of TCM, Hubei University of CM, Wuhan 430061.
- Publication Type:Journal Article
- Keywords:
acupuncture;
diarrhea type irritable bowel syndrome;
herbal-moxa plaster;
moxa-box moxibustion;
randomized controlled trial (RCT)
- MeSH:
Humans;
Spleen;
Irritable Bowel Syndrome/drug therapy*;
Quality of Life;
Yang Deficiency/drug therapy*;
Kidney;
Diarrhea
- From:
Chinese Acupuncture & Moxibustion
2023;43(6):617-621
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To compare the clinical efficacy between herbal-moxa plaster and moxa-box moxibustion for diarrhea type irritable bowel syndrome (IBS-D) of spleen and kidney yang deficiency.
METHODS:Eighty patients with IBS-D of spleen and kidney yang deficiency were randomly divided into a herbal-moxa plaster group and a moxa-box moxibustion group, 40 cases in each group. The patients in the two groups were treated with conventional acupuncture at Baihui (GV 20), Yintang (GV 24+), Zhongwan (CV 12) and bilateral Tianshu (ST 25), Yinlingquan (SP 9), and Taixi (KI 3), etc. In addition, the patients in the herbal-moxa plaster group were treated with herbal-moxa plaster (Wenyang Fuzheng ointment, composed of prepared monkshood, prepared evodia rutaecarpa, dried ginger, cinnamon, etc.) at Shenque (CV 8), Guanyuan (CV 4), Zhongwan (CV 12) and bilateral Tianshu (ST 25), Shenshu (BL 23) and Shangjuxu (ST 37); the patients in the moxa-box moxibustion group were treated with moxa-box moxibustion at the same acupoints as the herbal-moxa plaster group. The acupuncture-moxibustion treatment was provided once every other day for 4 weeks (14 treatments). Before and after treatment, the scores of clinical symptom of TCM, irritable bowel syndrome (IBS) symptom severity scale (IBS-SSS) and IBS quality of life scale (IBS-QOL) were compared between the two groups, and the clinical efficacy was evaluated.
RESULTS:Compared with those before treatment, each item scores and total scores of clinical symptom of TCM, and IBS-SSS scores in the two groups were reduced after treatment (P<0.05). The abdominal bloating score, stool frequency score and total score of clinical symptom of TCM as well as IBS-SSS score in the herbal-moxa plaster group were lower than those in the moxa-box moxibustion group (P<0.05). Compared with those before treatment, the IBS-QOL scores in the two groups were increased after treatment (P<0.05), and the IBS-QOL score in the herbal-moxa plaster group was higher than that in the moxa-box moxibustion group (P<0.05). The total effective rate was 92.5% (37/40) in the herbal-moxa plaster group, which was higher than 85.0% (34/40) in the moxa-box moxibustion group (P<0.05).
CONCLUSION:On the basis of conventional acupuncture treatment, herbal-moxa plaster could effectively improve the clinical symptoms and quality of life in IBS-D patients of spleen and kidney yang deficiency, and its efficacy is superior to that of moxa-box moxibustion.
